Role of Cytokines in Patients on Dialysis

Dinarello C.A. . lnterleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627–52.

Dinarello C.A. . lnterleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int 1992; 42: (Suppl 38) S68–77.

Dinarello C.A. . Cytokines: Agents provocateurs in hemodialysis. Kidney Int 1992; 41: 683–94.

David J.R. . Delayed hypersensitivity in vitro: Its mediated by cell-free substances formed by lymphoid cell-antigen interactions. Pro Nat Acad Sci USA 1966; 56: 72–7.

Bloom B.R. , Bennet B. . Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966; 153: 80–2.

Dinarello C.A. , Cannon B.D. , Wolff S.M. . New concepts on the pathogenesis of fever. Rev Infect Dis 1988; 10: 168–89.

Dumonde D.C. , Wolstencroft R.A. , Panayi G.S. , Mathew M. , Morley J. , Howson W.T. . “Lymphokines”: Non-antibody mediators of cellular immunity generated by lymphocite activation. Nature 1969, 224: 38–42.

Cohen S. , Bigazzi P.E. , Yoshida T. . Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol 1974; 12: 150–9.

Aarden L.A. , Mishell Rl , Brunner T.K. . Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors. J Immunol 1979; 123: 2928–9.

Vilcek J. , Le J. . Immunology of cytokines: An introduction. In: Thomson A. , ed. The cytokine handbook. San Diego Academic Press, 1991, 1–17.

Cheung A.K. . Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990; 150–61.

Cheung A.K. . Membrane biocompatibility. In: Nissenson A.R. , Fine R.N. , Gentile D.E. , eds. Clinical dialysis. Norwalk, CT, Appleton & Lange, 1990; 69–96.

Henderson L.W. , Koch K.M. , Dinarello C.A. , Shaldon S. . Hemodialysis hypotension: the inteleukin-1 hypothesis. Blood Purif 1983; 1: 2–8.

Vlassara H. . Advanced nonenzymatic tissue glycosylation: cell-mediated interactions implicated in the complications associated with diabetes and aging. Blood Purif 1990; 8: 223–32.

Beutler B. , Krochin N. , Milsark I.W. , Leudke C. , Cerami A. . Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistence. Science 1986; 232: 977–80.

Okusawa S. , Gelfand J.A. , Ikejuma T. , Connolly R.J. , Dinarello C.A. . Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cycloxygenease inhibition. J Clin Invest 1988, 81: 1162–72.

Smith J.W. , Urba W.J. , Curti B.D. . The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. J Clin Oncol 1992; 10: 1141–52.

Tewari A. , Buhles W.C. Jr. , Starnes H.F. Jr. Preliminary report: effects of interleukin-1 on platelet counts. Lancet 1990; 336: 712–14.

Dejana E. , Breviario F. , Erroi A. . Modulation of endothelial cell functions by different molecular species of interleukin 1. Blood 1987; 69: 695–99.

Feingold K.R. , Soued M. , Serio M.K. , Moser A.H. , Dinarello C.A. , Grunfeld C. . Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 1989; 125: 267–74.

Grunfeld C. , Soued M. , Adi S. , Moser A.H. , Dinarello C.A. , Feingold K.R. . Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferonalpha. Endocrinology 1990; 127: 46–54.

Dinarello C.A. , Rosenwasser L.J. , Wolff S.M. . Demonstratioin of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans. J Immunol 1981; 127: 2517–19.

Liao Z. , Grimshaw R.S. , Rosentreich D.L. . Identification of a specific interleukin-1 inhibitor in the urine of febrile patients. J Exp Med 1984; 159: 125–136.

Arend W.P. , Joslin F.G. , Thompson R.C. , Hannum C.H. . An IL-1 inhibitor for human monocytes. Production and characterization of biologic properties. J Immunol 1989; 143: 1851–58.

Seckinger P. , Dayer J.M. . lnterleukin-1 inhibitors. Ann Inst Pasteur/Immunol 1987; 138: 461–516.

Hannun C.H. , Wilcox C.J. , Arend W.P. . lnterleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336–40.

Carter D.B. , Deibel M.R.J. , Dunn C.J. . Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein (see comments). Nature 1990; 344: 633–8.

Eisenberg S.P. , Evans R.J. , Arend W.P. . Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343 341–6.

Seckinger P. , Lowenthal J.W. , Williamson K. , Dayer J.M. , MacDonald H.R. . A urine inhibitor of interleukin-1 activity that blocks ligand binding. J Immunol 1987, 139: 1546–9.

Dinarello C.A. . The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106–113.

Granowitz E.V. , Mancilla J. , Clark B.D. , Dinarello C.A. . The IL-1 receptor antagonist inhibits IL-1 binding to the type II IL-1 receptor. J Biol Chem 1991; 266: 14147–50.

Rambaldi A. , Torcia M. , Bettoni S. . Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991; 78: 3248–53.

Dripps D.J. , Brandhuber B.J. , Thompson R.C. , Eisenberg S.P. . Effet of IL-1ra on IL-1 signal transduction. J Biol Chem 1991; 266: 10331–6.

Ohlsson K. , Bjork P. , Bergenfeldt M. , Hageman R. , Thompson R.C. . Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550–2.

Fisher E. , Marano M.A. , van Zee K.J. . IL-1 receptor blockade improves survival and hemodynamic performance in E. coli septic shock, but fails to alter responses to sublethal endotoxemia. J Clin Invest 1992; 89: 1151–7.

Aiura K. , Gelfand J.A. , Burke J.F. , Thompson R.C. , Dinarello C.A. . Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1β in rabbits. Infect Immun 1993; 61: 3342–50.

Wakabayashi G. , Gelfand J.A. , Burke J.F. , Thompson R.C. , Dinarello C.A. . A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991; 5: 338–43.

Dinarello C.A. , Thompson RC . II-1: Effects of interleukin 1 receptor antagonist in vitro and in vivo. Immunol Today 1991; 12: 404–10.

Arend W.P. , Smith M.F.J. , Janson R.W. , Joslin F.G. . IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol 1991; 147: 1530–6.

Poutsiaka D. , Clark B.D. , Vannier E. , Dinarello C.A. . Production of interleukin-1 receptor antagonist and interleukin-1b peripheral blood mononuclear cells is differentially regulated. Blood 1991; 78: 1275–81.

Haskill S. , Martin M. , VanLe L. . cDNA cloning of a novel form of the interleukin-1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 1991; 88: 3681;5.

Maier J.A.M. , Voulalas P. , Roeder D. , Masiag T. . Extension, of the life span of human endothelial cells by an interleukin-1a antisense oligomer. Science 1990; 249: 1570–4.

Granowitz E.V. , Santos A. , Poutsiaka D.D. , Cannon J.G. , Wilmore D.A. , Wolff S.M. , Dinarello C.A. . Production of interleukin-1 receptor antagonist during experimental endotoxemia. Lancet 1991; 338: 1423–4.

Fischer E. , van Zee K.J. , Marana M.A. . Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992; 79: 2196–200.

Engelmann H. , Holtmann H. , Brakebusch C. . Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 1990; 265: 14497–504.

Olsson I. , Lantz M. , Nilsson E. . Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989; 42: 270–5.

Seckinger P. , Isaaz S. , Dayer J.M. . Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem 1989; 264: 11966–73.

Engelmann H. , Novick D. , Wallach D. . Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 1990; 265: 1531–6.

Nophar Y. , Kemper O. , Brakebusch C. . Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequences data of its soluble form, encodes both the cell surface and a soluble form of the receptor. Embo J 1990; 9: 3269–78.

Bingel M. , Lonnemann G. , Koch K.M. , Dinarello C.A. , Shaldon S. . Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes. Nephron 1988; 50: 273–6.

Descamps-Latscha B. , Herbelin A. , Nguyen A.T. , Uzan M. , Zingraff J. . Haemodialysis-membrane-induced phagocyte oxidative metabolism activation and interleukin-1 production. Life Supp Sys 1986; 4: 349–53.

Herbelin A. , Nguyen A.T. , Zingraff J. , Urena P. , Deschamps-Latscha B. . Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor. Kidney Int 1990; 37: 116–25.

Lonnemann G. , Bingel M. , Koch K.M. , Shaldon S. , Dinarello C.A. . Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res 1987; 6: 63–70.

Luger A. , Kovarik J. , Stummvol H.K. , Urbanska A. , Luger T. . Blood membrane interaction in hemodialysis leads to increased cytokine production. Kid Int, 1987; 32: 84–8.

Poignet J.L. , Fitting C. , Delons S. , Cavaillon J.M. . Circulating interleukin-6 in long term hemodialyzed patients (Abstract). J Am Soc Nephrol 1990; 1: 372.

Holmes C. , Evans R. , Ross D. , Frankamp P. . Plasma IL-1 and TNF levels during high flux hemodialysis with cellulose triacetate membranes (Abstract). Kidney Int 1990; 37: 301.

Powell A.C. , Bland L. , Oettiger C.W. . Lack of elevation of plasma interleukin-1β or tumor necrosis factor α during unfavorable hemodialysis conditions. J Am Soc Nephol 1991; 1007–13.

Michie H.R. , Manogue K.R. , Spriggs D.R. . Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481–6.

Cannon J.G. , Tompkins R.G. , Gelfand J.A. . Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Inf Dis 1990; 161: 79–84.

Cannon J.G. , Gelfand J.A. , Tompkins R.G. , Hegarty M.T. , Burke J.F. , Dinarello C.A. . Plasma IL-1β and TNFα levels in humans following cutaneos injury. Crit Care Med 1992; 20: 1414–9.

Kalechman Y. , Gafter U. , Srendi B. , Levi J. . Enhanced cytokine production by erythoprotein (Abstract). J Am Soc Nephrol 1990; 1: 400.

Pereira B.J.G. , Shapiro LS , King AJ , Strom J.A. , Dinarello C.A. . Plasma levels of pro-inflammatory cytokines and inhibitory proteins in chronic renal failure and dialysis patients (Abstract). Blood Purif 1992; 10: 103.

Pereira B.J.G. , Shapiro LS , King AJ , Storm J.A. , Dinarello C.A. . Plasma levels of pro-inflammatory cytokines and inhibitory proteins in patients with chronic renal failure (Abstract). J Am Soc Nephrol 1992; 3: 662.

Brockhaus M. , Bar-Khayim Y. , Gurwicz S. , Frensdorff A. , Haran N. . Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney Int 1992; 42: 663–7.

Blumenstein M. , Schmidt B. , Ward R.A. : Altered interleukin-1 production in patients undergoing hemodialysis. Nephron 1988; 50: 277–81.

Haeffner-Cavaillon N. , Cavaillon J.M. , Ciancioni C. . In vivo induction of interleukin-1 during hemodialysis. Kidney Int 1989; 35: 1212–8.

Lonnemann G. , Haubitz M. , Schindler R. . Hemodialysis-associated induction of cytokines. Blood Purif 1990; 8: 214–22.

Endres S. , Ghorbani R. , Lonnemann G. , van der Meer J.W.M. , Dinarello C.A. . Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol 1988; 49: 424–38.

Endres S. , Cannon J.G. , Ghorbani R. . In vitro production of IL-1β, ll-1α, TNF, and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19: 2327–33.

Lonnemann G. , Endres S. , van der Meer J.W. , Cannon J.G. , Dinarello C.A. . A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin. Lymphokine Res 1988; 7: 75–84.

Oettinger C.W. , Powell A.C. , Bland L.A. . Enhanced release of tumor necrosis factor alpha but not interleukin-1 beta by uremic blood stimulated with endotoxin (Abstract). J Am Soc Nephrol 1990; 1: 370.

Memoli B. , Rampino T. , Libetta C. , DalCanton A. , Andreucci V.E. . Peripheral blood leukocytes interleukin-6 production in uremic hemodialyzed patients (Abstract). J Am Soc Nephrol 1990; 1: 369.

Ryan J. , Beynon H. , Rees A.J. , Cassidy M.J.D. . Evaluation of in vitro production of tumor necrosis factor by monocytes in dialysis patients. Blood Purif 1991; 9: 142–7.

Schindler R. , Linnenweber S. , Schulze M. . Gene expression of interleukin-1β during hemodialysis. Kidney Int 1993; 43: 712–21.

Urena P. , Gogusev J. , Valdovinos R. , Herbelin A. , Drueke T. . Transcriptional induction of TNF-Alpha in uremic patients undergoing hemodialysis (Abstract). J Am Soc Nephrol 1990; 1: 380.

Schindler R. , Lonnemann G. , Shaldon S. , Koch K.M. , Dinarello C.A. . Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85–93.

Morin M. , Schindler R. , Wakabayashi G. , Daumy G. , Dinarello C.A. , Gelfand J.A. . Pilogram concentrations of endotoxin stimulate synthesis of IL-1 beta and TNF alpha by human peripheral blood mononuclear cells exposed to recominant human C5a. Eur Cytokine Network 1991; 2: 27–30.

Haeffner C.N. , Cavaillon J.M. , Laude M. , Kazatchkine M.D. . C3a (C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 1987; 139: 794–9.

Okusawa S. , Dinarello C.A. , Yancey K.B. . C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J Immunol 1987; 139: 2635–40.

Lonnemann G. , Bingel M. , Floege J. , Koch K.M. , Shaldon S. , Dinarello C.A. . Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 1988; 33: 29–35.

Bingel M. , Lonnemann G. , Shaldon S. , Koch K.M. , Dinarello C.A. . Human interleukin-1 production during hemodialysis. Nephron 1986; 43: 161–3.

Evans R.C. , Holmes C.J. . In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif 1991; 9: 92–101.

Lonnemann G. , Beheme T.C. , Lenzer B. . Permeability of dialyzer membranes to TNFα-inducing substances from water bacteria. Kidney Int 1992; 42: 61–8.

Lonnemann G. , Mahiout A. , Schindler R. , Colton C.K. . Pyrogen retention by the polyamide membranes. In: Shaldon S. , Koch K.M. , eds. Polyamide-the evolution of a synthetic membrane for renal therapy. Contr Nephrol, Karger, Basel 1992; 96: 47–63.

Loppnow H. , Brade H. , Durrbaum I. . IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 1989; 142: 3229–38.

Laude-Sharp M. , Caroff M. , Simard L. , Pulineri C. , Kazatchkine M.D. , Haeffner-Cavaillon N. . Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int 1990; 38: 1089–94.

Urena P. , Herbelin A. , Zingraff J. . Permeability of cellulosic and non-celIulosic membranes to endotoxins and cytokine production during in vitro hemodialysis. Nephrol Dial Transplant 1992; 7: 1–28.

Laude-Sharp M. , Caroff M. , Simard L. , Pulineri C. , Kazatchkine M.D. , Haeffner-Cavaillon N. . Dissociation between the interleukin-1-inducing capacity and limulus reactivity of lipopolysaccharides from gram-negative bacteria. Cytokine 1990; 2: 253–8.

Tobias P.S. , Soldau K. , Ulevitch F.J. . Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989; 264: 10867–71.

Schumann R.R. , Leong S.R. , Flagg G.W. , Gray P.W. , Wright S.D. , Mathison J.C. , Tobias P.S. , Ulevitch R.J. . Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429–31.

Ramadori G. , Meyer zum , Buschenfeld Kh , Tobias P.S. , Mathison J.C. , and Ulevitch R.J. . Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathobiology 1990; 58: 89–94.

Mathison J.C. , Virca G.D. , Wolfson E. , Tobias P.S. , Glaser K. , Ulevitch R.J. . Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 1990; 85: 1108–18.

Mathison J. , Tobias P. , Wolfson E. , Ulevitch R. . Regulatory mechanisms of host responsiveness to endotoxin (lipopolysaccharide). Pathology 1991; 59: 185–8.

Wright S.D. , Tobias P.S. , Ulevitch R.J. , Ramos R.A. . Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 1989; 170: 1231–41.

Wright S.D. , Ramos R.A. , Tobias P.S. , Ulevitch R.J. , Mathison J.C. . CD 14 a receptor for comlexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431–3.

Pereira H.A. , Spitznagel J.K. , Winton E.F. . The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population. Blood 1990; 76: 825–34.

Marra M.N. , Wilde C.G. , Griffith J.E. , Snable J.L. , Scott R.W. . Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol 1990; 144: 662–6.

Marra M.N. , Wilde C.G. , Collins M.S. , Snable J.L. , Thornton M.B. , Scott R.W. . The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 148: 532–7.

Pereira B.J.G. , Poutsiaka D.D. , Strom J.A. . In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 1992; 1419–24.

Andersson J. , Bjork L. , Dinarello C.A. , Towbin H. , Andersson U. . Lipopolysaccharide induces human interleukin 1 receptor antagonist and interleukin 1 production in the same cell. Europe J Immunol 1992; 22: 2617–23.

Pereira B.J.G. , Dinarello C.A. . Recent advances in cytokine production in patients on dialysis. Abstracts of XIIth International Congress of Nephrology, Jerusalem, June 13–18 1993; 302.